InvoCare is under Algo Engine buy conditions.

In mid-April IVC announced up to $250m equity raising
at $10.40/share.

April revenue was down 13% and we’re seeing costs higher than
anticipated. Improvement in trading conditions should occur as the partial easing of restrictions take place.

We assume 2020 earnings will be down 10% and see a recovery into 2021 & 2022.

We’ll revisit IVC if it trades back below $10.00

Invocare – Offers Long-Term Value

InvoCare is under current Algo Engine sell conditions, following a recent lower high formation at $15.00.

Invocare’s balance sheet will be strengthened following the announced raising of up to A$85m, via institutional placement which will include $20m via a share purchase plan. We expect this to be done at around $13.30.

We anticipate the next signal to be a Algo Engine “buy” and we’re likely to see this before the end of April.

We see long-term value in IVC and suggest investors watch for an entry signal between $13.30 & $13.80




Algo Update – Invocare

Our Algo Engine triggered a recent buy signal in IVC and the stock has continued to drift lower.

The next range of support is $14.30 , followed by the up trending support line marked as “support 2” in the graph below.

The negative price action over recent days is being driven by the market’s reaction to a change in industry competition in the UK and concerns that similar challenges may emerge in Australia.

IVC reports full year earnings result on 19th February.